Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
Clinical trial NCT01928680 · UNKNOWN
Trial details
- NCT number
- NCT01928680
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.